Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_assertion type Assertion NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_head.
- NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_assertion description "[Antagonists of the effect of lung cancer-derived galectin-1 on DCs and anti-HB-EGF blocking antibodies could, therefore, have therapeutic potential as antitumor agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_provenance.
- NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_assertion evidence source_evidence_literature NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_provenance.
- NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_assertion SIO_000772 22291012 NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_provenance.
- NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_assertion wasDerivedFrom befree-20150227 NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_provenance.
- NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_assertion wasGeneratedBy ECO_0000203 NP535298.RAIJ5z1NXF_VR9_-lCeH29vCh7YGDC-iC1C-_w-oRZKjI130_provenance.